Artemis Medicare Services Limited Submits Business Responsibility and Sustainability Report for FY2025-26

6 min read     Updated on 07 Jul 2026, 08:09 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Artemis Medicare Services Limited filed its BRSR for FY2025-26 on July 7, 2026, disclosing standalone ESG, workforce, and environmental performance data. The company employs 399 employees and 1,677 workers, with all receiving above-minimum-wage remuneration. Key sustainability milestones include achieving IGBC Platinum Rating certification, installing rooftop solar systems of 150 kW and 60 kW, and targeting approximately 30% Scope 2 emission reduction for FY2026-27. Total waste generated was 274.71 metric tonnes in FY2025-26, and total water consumption was 92,145 kilolitres.

powered bylight_fuzz_icon
44980738

*this image is generated using AI for illustrative purposes only.

Artemis Medicare Services Limited filed its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26 on July 7, 2026, in compliance with Regulation 34(2)(f) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report was submitted by Poonam Makkar, Company Secretary and Compliance Officer, and forms part of the company's Annual Report for FY2025-26. The disclosures are made on a standalone basis, covering the entity's operations at three national facilities, with no international offices.

Corporate Overview and Business Activities

Artemis Medicare Services Limited, incorporated in 2004, operates from its corporate address at Artemis Hospital, Sector-51, Gurugram-122001, Haryana. The company's paid-up capital stands at Rs. 15,83,06,247. The following table summarises the company's primary business activity and its contribution to total turnover:

Parameter: Details
Main Activity: Healthcare Services
Business Activity: Multi-specialty Medical Services
% of Turnover: 99.56%
NIC Code: 86100
Reporting Boundary: Standalone Basis
Financial Year: 2025-26

The company has one holding company (Constructive Finance Private Limited) and one subsidiary (Artemis Cardicare Private Limited, with a 65% shareholding). Neither entity participates in the Business Responsibility initiatives of the listed entity.

Workforce Composition and Employee Benefits

The BRSR provides detailed disclosures on the company's workforce for FY2025-26. The total employee count stands at 399, comprising 291 males (72.93%) and 108 females (27.07%). The total worker count is 1,677, comprising 746 males (44.48%) and 931 females (55.52%). The Board of Directors comprises 10 members, of whom 3 (30.00%) are female. Key Managerial Personnel total 3, of whom 2 (66.67%) are female.

The following table presents employee and worker turnover rates across three financial years:

Category: FY2025-26 Male FY2025-26 Female FY2025-26 Total FY2024-25 Male FY2024-25 Female FY2024-25 Total FY2023-24 Male FY2023-24 Female FY2023-24 Total
Permanent Employees: 13.73% 9.09% 12.53% 11.52% 4.55% 9.80% 13.74% 20.12% 15.36%
Permanent Workers: 42.41% 50.58% 46.99% 40.03% 49.54% 45.26% 35.71% 50.72% 43.72%

All permanent employees and workers receive remuneration above the minimum wage. The median remuneration for key categories in FY2025-26 is detailed below:

Category: Male Number Male Median Remuneration Female Number Female Median Remuneration
Board of Directors: Nil Nil 1 Rs. 5,268.59 Lacs
Key Managerial Personnel: 1 Rs. 113.74 Lacs 1 Rs. 69.61 Lacs
Employees other than BoD and KMP: 290 Rs. 11.32 Lacs 106 Rs. 10.12 Lacs
Workers: 746 Rs. 4.41 Lacs 931 Rs. 3.84 Lacs

Gross wages paid to females as a percentage of total wages stood at 41.64% in FY2025-26, compared to 40.82% in FY2024-25. Well-being measures cost incurred as a percentage of total revenue was 0.43% in FY2025-26 and 0.47% in FY2024-25. The Lost Time Injury Frequency Rate (LTIFR) and total recordable work-related injuries for both employees and workers were nil in both FY2025-26 and FY2024-25. No fatalities or high-consequence work-related injuries were reported in either year.

ESG Governance and Policy Framework

The company's ESG governance is overseen by a Business Responsibility and Sustainability Committee. The highest authority responsible for implementation and oversight of Business Responsibility policies is Dr. Devlina Chakravarty, Managing Director. Key policies—including the Business Responsibility and Sustainability Policy, Code of Conduct for Directors and Senior Management, Anti-Bribery Fraud and Corruption Policy, Corporate Social Responsibility Policy, Equal Employment Opportunity Policy, Privacy Policy, Related Party Transactions Policy, and Whistle Blower Policy—have all been approved by the Board and translated into procedures. Performance against policies and compliance with statutory requirements are reviewed annually by the Committee of the Board across all nine NGRBC principles.

The company holds accreditations and certifications mapped to its NGRBC principles, including Joint Commission International (JCI), National Accreditation Board for Hospitals and Healthcare Providers (NABH-H, NABH-BB, NABH-EC, NABH-NE, NABH-ES), National Accreditation Board for Testing and Calibration of Laboratories (NABL), and ISO 27001 (Information Security Management System).

Sustainability Initiatives and Environmental Performance

The company achieved the IGBC Platinum Rating certification during FY2025-26, reflecting its commitment to green building practices and sustainable infrastructure. An Organic Waste Composter (OWC) machine was operationalised for on-site treatment of organic waste. Key sustainability initiatives undertaken include:

  • Renewable Energy Adoption: Installation of rooftop solar power systems with capacities of 150 kW and 60 kW; installation of solar water heaters.
  • Energy Efficiency & Optimization: Installation of Variable Frequency Drives (VFDs) and heat pumps in HVAC systems; replacement of conventional fans with energy-efficient fans in cooling towers.
  • Emission Reduction & Air Quality Management: Installation of Retrofit Emission Control Devices (RECDs) in diesel generators to reduce particulate matter (PM), SOx, and NOx emissions; installation of a new diesel generator (DG) set with improved emission and efficiency standards.
  • Water Conservation: Installation of water aerators across facilities; enhancement of rainwater harvesting (RWH) capacity.
  • Transition to Cleaner Fuels: Replacement of Liquefied Petroleum Gas (LPG) with Piped Natural Gas (PNG) in kitchen operations.

The following table summarises key energy and environmental metrics for FY2025-26 and FY2024-25:

Parameter: FY2025-26 FY2024-25
Total energy consumed from renewable sources (GJ): 696 406
Total electricity from non-renewable sources (GJ): 62,309 57,306
Total fuel from non-renewable sources (GJ): 7,731 10,937
Total energy from non-renewable sources (GJ): 70,040 68,243
Total energy consumed (GJ): 70,736 68,649
Energy intensity per lacs rupee of turnover: 0.667 0.752
Total Scope 1 emissions (metric tonnes CO2 equivalent): 2,680.99 3,977.93
Total Scope 2 emissions (metric tonnes CO2 equivalent): 12,288.81 11,572.80
Total Scope 1 & 2 emission intensity per lacs rupee of turnover: 0.141 0.170
Total water withdrawal (kilolitres): 1,18,835 1,46,008
Total water consumption (kilolitres): 92,145 1,17,461
Water intensity per lacs rupee of turnover: 0.87 1.286
Total waste generated (metric tonnes): 274.71 267.43
Waste intensity per lacs rupee of turnover: 0.0026 0.0029

For FY2026-27, the company has set a target of approximately 30% reduction in Scope 2 emissions through a third-party offsite solar energy plant, to be introduced in a phased manner.

Stakeholder Grievances and Compliance

The company has grievance redressal mechanisms in place for all stakeholder groups. During FY2025-26, 148 customer complaints were filed (nil pending at year-end), compared to 553 in FY2024-25 (nil pending). One shareholder complaint was filed in FY2025-26 (nil pending), with nil in FY2024-25. Community complaints stood at nil in FY2025-26 versus 2 in FY2024-25. No complaints related to sexual harassment, discrimination, child labour, forced labour, or wages were filed in either FY2025-26 or FY2024-25.

A monetary penalty of Rs. 10,00,000 was imposed by the Office of the Collector of Stamps, Government of NCT of Delhi, under NGRBC Principle 1, related to delayed filing of an application for determination of stamp duty. No appeal has been preferred. The company reported compliance with all applicable environmental laws, regulations, and guidelines in India, and received no adverse orders from regulatory authorities related to anti-competitive conduct during the current financial year.

CSR and Community Engagement

The company is a member of several industry associations including ASSOCHAM (National), PHD Chamber of Commerce and Industry (National), Federation of Indian Industry Haryana (State), and others. CSR projects undertaken during FY2025-26 include the Green Belt Initiative, Boondh-Rainwater Conservation (benefiting 7,107 persons, 100% from vulnerable groups), Conservation of Solar Energy (benefiting 2,300 persons, 100% from vulnerable groups), It's a FIGHt bK-Tuberculosis Elimination Programme (benefiting 45,553 persons, 100% from vulnerable groups), and Menstrual Health & Hygiene Management (benefiting 4,000 persons, 100% from vulnerable groups). Procurement directly sourced from MSMEs/small producers stood at 52.02% in FY2025-26 versus 53.17% in FY2024-25, and 97.94% was sourced directly from within India in FY2025-26.

Historical Stock Returns for Artemis Medicare Services

1 Day5 Days1 Month6 Months1 Year5 Years
-1.05%+3.96%+5.92%+1.11%+8.20%+677.78%

How will the planned 30% reduction in Scope 2 emissions impact Artemis Medicare's operating costs and energy reliability during the transition to the third-party offsite solar plant?

What specific strategies will the company implement to address the high turnover rate among permanent workers, which exceeded 46% in FY2025-26?

Will the company consider integrating its subsidiary, Artemis Cardicare Private Limited, into its Business Responsibility initiatives to standardize ESG reporting across the group?

Artemis Medicare Services
View Company Insights
View All News
like17
dislike

Artemis Medicare fixes record date for Re. 0.45 dividend

1 min read     Updated on 24 Jun 2026, 05:20 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Artemis Medicare Services has fixed July 10, 2026 as the record date for a final dividend of Re. 0.45 per equity share for FY26, subject to AGM approval. The company detailed TDS rates and documentation requirements for residents and non-residents, with a document submission deadline of July 15, 2026. The 22nd AGM is scheduled for July 31, 2026.

powered bylight_fuzz_icon
43407658

*this image is generated using AI for illustrative purposes only.

Artemis Medicare Services has fixed Friday, July 10, 2026 as the record date for the payment of a final dividend of Re. 0.45 per equity share for the financial year 2025-26. The dividend, amounting to 45% of the face value of Re. 1 each, was recommended by the Board of Directors on May 8, 2026. The payout is subject to shareholder approval at the upcoming Annual General Meeting (AGM) and will be made within 30 days of the meeting to eligible shareholders.

The company has communicated the applicable provisions of the Income-tax Act, 2025 regarding Tax Deduction at Source (TDS) or withholding tax on the dividend. The company is required to deduct tax at source before payment, with rates varying based on the shareholder's residential status and documentation submitted. Resident shareholders with valid PAN linked to Aadhar face a 10% TDS, while those without valid PAN may be subject to a 20% deduction. Non-resident shareholders face a withholding tax of 20% plus surcharge and cess, unless they opt for benefits under the Double Taxation Avoidance Agreement (DTAA).

Shareholders must submit relevant tax documents to the Registrar and Transfer Agent, Alankit Assignments Limited, by Wednesday, July 15, 2026, to ensure the appropriate tax rate is applied. Documents required for DTAA benefits include a Tax Residency Certificate, Electronic Form 41, and a self-declaration regarding tax residency and beneficial ownership. The company clarified that it is not obligated to apply beneficial DTAA rates if the documentation is incomplete or unsatisfactory.

The 22nd AGM of the company is scheduled for Friday, July 31, 2026. Shareholders whose names appear as beneficial owners or in the register of members as of the close of business hours on July 10, 2026, will be entitled to the dividend. The company emphasized that dividend payments will be made only through electronic mode, and shareholders must ensure their bank account details are updated with their depository participants or the registrar.

Key AGM Dates

Particulars Date(s)
Cut-off date for AGM Notice/Annual Report June 26, 2026 (Friday)
Cut-off date for e-Voting entitlement July 24, 2026 (Friday)
Remote e-Voting period July 28, 2026 (9:00 A.M.) to July 30, 2026 (5:00 P.M.)
Record Date for Dividend July 10, 2026 (Friday)
22nd AGM July 31, 2026 (Friday)

Historical Stock Returns for Artemis Medicare Services

1 Day5 Days1 Month6 Months1 Year5 Years
-1.05%+3.96%+5.92%+1.11%+8.20%+677.78%

How will the new Income-tax Act provisions impact overall dividend yield attractiveness for non-resident investors?

What is the expected shareholder turnout and approval rate for the dividend proposal at the upcoming AGM?

Will Artemis Medicare Services maintain this dividend payout ratio in the next financial year given future capital requirements?

Artemis Medicare Services
View Company Insights
View All News
like15
dislike

More News on Artemis Medicare Services

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:+8.20%